• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SI Xiaofei,WANG Shuhua,LI Yanjie,JIANG Dianzhuo.Discussion on the research of supplemental applications for post-approval oral modified-release formulations[J].Journal Of Pharmaceutical Research,2026,45(2):188-191,229[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3098times   Download 894次 QR Code for this article
Scan with your phone!
口服调释制剂的补充申请变更研究探讨
司晓菲,王淑华,李艳杰,姜典卓
Font:Larger+|Default|Smaller-
(国家药品监督管理局药品审评中心,北京 100076)
摘要:
化学药品上市后变更是药品全生命周期的重要部分。药学变更对调释制剂的安全、有效和质量可控性产生影响的可能性更大。一些口服调释制剂在变更批量、变更注册标准、变更贮藏条件和增加规格时,研究者需按重大变更申报补充申请。本文结合部分化学口服调释制剂上市后变更具体情形,简要论述变更风险评估和变更研究中的药学考虑,期望为变更研究评估和管理提供启示参考。
关键词:  上市后变更  口服调释制剂  补充申请  变更研究
DOI:10.13506/j.cnki.jpr.2026.02.011
基金项目:
Publication Date:February 25, 2026
Discussion on the research of supplemental applications for post-approval oral modified-release formulations
SI Xiaofei,WANG Shuhua,LI Yanjie,JIANG Dianzhuo
(Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China)
Abstract:
The post-approval CMC(chemical, manufacturing and control)changes are important parts of pharmaceutical product lifecycle. The changes considered to have a substantial potential to have a significant effect on safety, efficacy and quality of modified-release formulations. The pharmaceutical sponsors who intend to change the batch size,specification,storage condition and strength of some oral modified-release formulations should submit supplemental applications for major changes. Based on specific cases of oral modified-release formulations, the pharmaceutical considerations were put forward to assess the effects of the change and change research, in order to provide references for conduct change research and management.
Key words:  Post-approval change  Oral modified-release formulations  Supplemental applications  Change research
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.